Journal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.

Applied Neuropsychology-Adult is a premier journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to advancing the field of neuropsychology with a particular focus on adult populations. Since its inception in 2012, this journal has been a vital platform for disseminating innovative research, reviews, and clinical insights into the cognitive and psychological processes that influence adult behavior and functioning. With an impressive Scopus ranking, including Q3 status in both Developmental and Educational Psychology and Neuropsychology and Physiological Psychology, it demonstrates a commitment to high-quality scholarship that informs both clinical practice and theoretical understanding. Researchers, clinicians, and students alike will benefit from the journal's commitment to open access, providing broad access to valuable knowledge in the domain of neuropsychology. As it converges towards its 2024 milestone, Applied Neuropsychology-Adult continues to be an essential resource for those seeking to deepen their understanding of neuropsychological processes and their application in real-world settings.

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

Cognitive Neuropsychiatry is a distinguished academic journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to the intersection of cognitive neuroscience and psychiatry. With a strong commitment to advancing knowledge in these rapidly evolving fields, this journal provides a platform for high-quality, peer-reviewed research that explores cognitive processes underlying psychiatric disorders. Aiming to bridge gaps between neuroscience and clinical practice, it serves as an essential resource for researchers, professionals, and students alike. As evidenced by its performance metrics, the journal ranks in the Q2 quartile for Psychiatry and Mental Health, and Q3 for Cognitive Neuroscience, showcasing its relevance and growing impact, particularly among a competitive audience. While it does not currently offer open access options, Cognitive Neuropsychiatry remains a vital outlet for disseminating impactful findings, offering insights that shape contemporary psychiatric understanding and interventions.

EXPERIMENTAL AGING RESEARCH, published by Taylor & Francis Inc., is a leading journal that has been at the forefront of aging research since its inception in 1975. With an ISSN of 0361-073X and an E-ISSN of 1096-4657, this journal has earned a notable reputation, including a Q3 ranking in the field of Aging and impressive Q1 and Q2 rankings in Arts and Humanities and Geriatrics and Gerontology respectively. This positions the journal within the top percentile of its category, highlighting its significant impact and contribution to the scientific community. Covering a broad scope that intersects various disciplines, EXPERIMENTAL AGING RESEARCH aims to disseminate pioneering research, foster interdisciplinary collaboration, and provide a platform for innovative studies that enhance understanding of the aging process. While it currently does not offer Open Access, researchers and academics can access its rich repository of knowledge that spans multiple facets of aging, from physiological changes to psychological impacts. As the field of aging continues to evolve, this journal remains an essential resource for researchers, professionals, and students dedicated to advancing knowledge and practices concerning aging and longevity.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.

Cognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published by WILEY, stands at the forefront of research in the fields of neurology and psychiatry. As an Open Access journal since 2015, it fosters transparency and accessibility in sharing critical knowledge pertaining to the diagnosis, assessment, and monitoring of Alzheimer’s disease and related dementias. With an impressive impact factor reflected in its Q1 rankings in both Neurology (Clinical) and Psychiatry and Mental Health, this journal is recognized for its significant contribution to advancing understanding and improving clinical practices, as evidenced by its Scopus rankings in the top percentiles. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and methodologies that shape the future of dementia care, enhancing both patient outcomes and the scientific community's response to this pressing health challenge. With its headquarters located in Hoboken, NJ, this journal is a pivotal platform for disseminating high-quality, peer-reviewed research that strives to combat one of the most challenging areas in medicine today.